Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy

Although patients undergo procedures with curative intent for early‐stage hepatocellular carcinoma (HCC), up to 70% of patients may have disease recurrence in the liver at 5 years. Thus far, no therapy has proven to be effective in the adjuvant setting. Here, we discuss the application of immune‐bas...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2019-10, Vol.70 (4), p.1437-1442
Hauptverfasser:	Brown, Zachary J., Greten, Tim F., Heinrich, Bernd
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!